Assessment of the Electrophysiological Effects of Doxorubicin in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes

被引：0
作者：
Goineau, S. [1 ]
Hunault, M. [1 ]
Legrand, C. [1 ]
Hayes, E. [1 ]
Froget, G. [1 ]
Castagne, V. [1 ]
机构：
[1] Porsolt SAS, Le Genest St Isle, France
来源：
INTERNATIONAL JOURNAL OF TOXICOLOGY | 2018年 / 37卷 / 01期
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
P517
引用
收藏
页码：95 / 96
页数：2
相关论文
共 50 条
  • [21] Flagellin-Induced Immune Response in Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes
    Yuecel, Goekhan
    Zhou, Xiaobo
    Terkatz, Linda
    Wendel, Angela
    Reinhardt, Julius
    El-Battrawy, Ibrahim
    Sattler, Katherine
    Cyganek, Lukas
    Utikal, Jochen
    Langer, Harald
    Scharf, Ruediger
    Duerschmied, Daniel
    Akin, Ibrahim
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2023, 24 (18)
  • [22] HUMAN MYOFIBROBLASTS INCREASE THE ARRHYTHMOGENIC POTENTIAL OF HUMAN-INDUCED PLURIPOTENT STEM CELL-DERIVED CARDIOMYOCYTES
    Johnson, R. D.
    Mcvey, J. H.
    Camelliti, P.
    CARDIOVASCULAR DRUGS AND THERAPY, 2020, 34 (02) : 280 - 281
  • [23] Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Chaudhari, Umesh
    Ellis, James K.
    Wagh, Vilas
    Nemade, Harshal
    Hescheler, Jurgen
    Keun, Hector C.
    Sachinidis, Agapios
    AMINO ACIDS, 2017, 49 (12) : 1955 - 1963
  • [24] Evaluation of doxorubicin-induced cardiotoxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Hunault, Marion
    Legrand, Christophe
    Castagne, Vincent
    Goineau, Sonia
    TOXICOLOGY LETTERS, 2017, 280 : S255 - S255
  • [25] Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes
    Gökhan Yücel
    Zhihan Zhao
    Ibrahim El-Battrawy
    Huan Lan
    Siegfried Lang
    Xin Li
    Fanis Buljubasic
    Wolfram-Hubertus Zimmermann
    Lukas Cyganek
    Jochen Utikal
    Ursula Ravens
    Thomas Wieland
    Martin Borggrefe
    Xiao-Bo Zhou
    Ibrahim Akin
    Scientific Reports, 7
  • [26] Metabolite signatures of doxorubicin induced toxicity in human induced pluripotent stem cell-derived cardiomyocytes
    Umesh Chaudhari
    James K. Ellis
    Vilas Wagh
    Harshal Nemade
    Jürgen Hescheler
    Hector C. Keun
    Agapios Sachinidis
    Amino Acids, 2017, 49 : 1955 - 1963
  • [27] Lipopolysaccharides induced inflammatory responses and electrophysiological dysfunctions in human-induced pluripotent stem cell derived cardiomyocytes
    Yuecel, Gokhan
    Zhao, Zhihan
    El-Battrawy, Ibrahim
    Lan, Huan
    Lang, Siegfried
    Li, Xin
    Buljubasic, Fanis
    Zimmermann, Wolfram-Hubertus
    Cyganek, Lukas
    Utikal, Jochen
    Ravens, Ursula
    Wieland, Thomas
    Borggrefe, Martin
    Zhou, Xiao-Bo
    Akin, Ibrahim
    SCIENTIFIC REPORTS, 2017, 7
  • [28] International Multisite Study of Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Drug Proarrhythmic Potential Assessment
    Blinova, Ksenia
    Dang, Qianyu
    Millard, Daniel
    Smith, Godfrey
    Pierson, Jennifer
    Guo, Liang
    Brock, Mathew
    Lu, Hua Rong
    Kraushaar, Udo
    Zeng, Haoyu
    Shi, Hong
    Zhang, Xiaoyu
    Sawada, Kohei
    Osada, Tomoharu
    Kanda, Yasunari
    Sekino, Yuko
    Pang, Li
    Feaster, Tromondae K.
    Kettenhofen, Ralf
    Stockbridge, Norman
    Strauss, David G.
    Gintant, Gary
    CELL REPORTS, 2018, 24 (13): : 3582 - 3592
  • [29] Evaluation of chronic drug-induced electrophysiological and cytotoxic effects using human-induced pluripotent stem cell-derived cardiomyocytes (hiPSC-CMs)
    Altrocchi, C.
    Van Ammel, K.
    Steemans, M.
    Kreir, M.
    Tekle, F.
    Teisman, A.
    Gallacher, D. J.
    Lu, H. R.
    FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [30] Challenges and innovation: Disease modeling using human-induced pluripotent stem cell-derived cardiomyocytes
    Reilly, Louise
    Munawar, Saba
    Zhang, Jianhua
    Crone, Wendy C. C.
    Eckhardt, Lee L. L.
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
12345